Texier-Maugein J, Fourche J, Mormede M, Mazaud C, Bébéar C
Pathol Biol (Paris). 1986 May;34(5):415-8.
In vitro activity of azlocillin, gentamicin, and amikacin, alone or in combination was evaluated against 200 clinical isolates of Pseudomonas aeruginosa. The minimum inhibitory concentrations (MICs) were determined by a standard technique. For the evaluation of synergistic activities, one antibiotic was added in a concentration equivalent to one-fourth its MIC to increasing concentrations of the other antibiotic. The MIC for 50% of the strains was 3.25 micrograms/ml for gentamicin, 3 micrograms/ml for amikacin and 7 micrograms/ml for azlocillin. No significant difference could be seen between the two combinations, the percentage of synergy was 37% for azlocillin-gentamicin and 36% for azlocillin-amikacin. No antagonism was observed.
对阿洛西林、庆大霉素和阿米卡星单独或联合使用时针对200株铜绿假单胞菌临床分离株的体外活性进行了评估。最低抑菌浓度(MIC)通过标准技术测定。为评估协同活性,将一种抗生素以相当于其四分之一MIC的浓度添加到另一种抗生素不断增加的浓度中。50%菌株的庆大霉素MIC为3.25微克/毫升,阿米卡星为3微克/毫升,阿洛西林为7微克/毫升。两种联合用药之间未见显著差异,阿洛西林-庆大霉素的协同百分比为37%,阿洛西林-阿米卡星为36%。未观察到拮抗作用。